Variant report

Variant	esv3489432
Chromosome Location	chr16:30912801-30914799
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:38)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:38 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:30912530..30915248-chr16:30945909..30947809,2	K562	blood:
2	chr16:30792183..30793764-chr16:30912337..30915253,2	K562	blood:
3	chr16:30815388..30818380-chr16:30912110..30914364,3	MCF-7	breast:
4	chr16:30758037..30760213-chr16:30913543..30915112,2	K562	blood:
5	chr16:30912902..30918884-chr16:30920570..30924921,9	MCF-7	breast:
6	chr16:30900115..30901771-chr16:30911321..30913691,2	K562	blood:
7	chr16:30785888..30788554-chr16:30910264..30913516,3	MCF-7	breast:
8	chr16:30910564..30915241-chr16:30931582..30935352,8	MCF-7	breast:
9	chr16:30886272..30886934-chr16:30913564..30914135,2	MCF-7	breast:
10	chr16:30912133..30914128-chr16:30982140..30985012,2	MCF-7	breast:
11	chr16:30786539..30788362-chr16:30912397..30914533,2	MCF-7	breast:
12	chr16:30912851..30916302-chr16:30932424..30935969,6	K562	blood:
13	chr16:30668862..30670603-chr16:30912854..30914439,2	MCF-7	breast:
14	chr16:30912499..30918732-chr16:30930262..30935475,13	MCF-7	breast:
15	chr16:30912898..30915035-chr16:30962438..30965039,2	MCF-7	breast:
16	chr16:30913615..30915128-chr16:31190546..31193094,2	K562	blood:
17	chr16:30912249..30916036-chr16:30924417..30927722,3	K562	blood:
18	chr16:30913031..30919294-chr16:30922948..30927916,8	MCF-7	breast:
19	chr16:30855664..30857154-chr16:30912896..30914067,10	K562	blood:
20	chr16:30904975..30905502-chr16:30913182..30914127,2	K562	blood:
21	chr16:30855742..30856347-chr16:30913359..30913900,3	MCF-7	breast:
22	chr16:30785578..30788254-chr16:30911758..30913330,2	K562	blood:
23	chr16:30884479..30890188-chr16:30910598..30915198,10	MCF-7	breast:
24	chr16:30822842..30825891-chr16:30913265..30916263,3	K562	blood:
25	chr16:30796087..30799228-chr16:30911236..30914996,3	MCF-7	breast:
26	chr16:30815951..30818451-chr16:30913360..30915131,3	MCF-7	breast:
27	chr16:30886090..30888466-chr16:30911609..30914584,5	K562	blood:
28	chr16:30876290..30879786-chr16:30913086..30915065,3	MCF-7	breast:
29	chr16:30856093..30856659-chr16:30913341..30914126,4	MCF-7	breast:
30	chr16:30758037..30761391-chr16:30912017..30915043,4	K562	blood:
31	chr16:30913321..30915990-chr16:30931581..30936330,6	K562	blood:
32	chr16:30894706..30896281-chr16:30913366..30915721,2	K562	blood:
33	chr16:30884422..30889769-chr16:30911523..30915041,8	MCF-7	breast:
34	chr16:30890237..30893822-chr16:30910547..30914348,3	MCF-7	breast:
35	chr16:30715974..30718452-chr16:30912290..30914014,2	K562	blood:
36	chr16:30803684..30806177-chr16:30912037..30915319,3	MCF-7	breast:
37	chr16:30789163..30792393-chr16:30910232..30915668,5	K562	blood:
38	chr16:30885099..30888289-chr16:30911609..30917260,6	K562	blood:

No data

Variant related genes	Relation type
ENSG00000099385	chromatin interactions
ENSG00000265991	chromatin interactions
ENSG00000089280	chromatin interactions
ENSG00000260852	chromatin interactions
ENSG00000260083	chromatin interactions
ENSG00000156873	chromatin interactions
ENSG00000156860	chromatin interactions
ENSG00000099364	chromatin interactions
ENSG00000211591	chromatin interactions
ENSG00000102870	chromatin interactions
ENSG00000230447	chromatin interactions
ENSG00000262026	chromatin interactions

Extended variants
information (count: 61 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:61 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145522836	chr16:30912842-30912843	Weak transcription Active TSS Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
2	rs576365334	chr16:30912868-30912869	Weak transcription Active TSS Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
3	rs148840677	chr16:30912886-30912887	Weak transcription Active TSS Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
4	rs563669343	chr16:30912969-30912970	Weak transcription Active TSS Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
5	rs529510805	chr16:30913005-30913006	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
6	rs11860383	chr16:30913044-30913045	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
7	rs559946497	chr16:30913045-30913046	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
8	rs34511901	chr16:30913087-30913088	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
9	rs118151917	chr16:30913195-30913196	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
10	rs552272991	chr16:30913314-30913315	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
11	rs186725199	chr16:30913382-30913383	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
12	rs397516646	chr16:30913386-30913387	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
13	rs397516645	chr16:30913389-30913390	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
14	rs145280280	chr16:30913405-30913406	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
15	rs112567717	chr16:30913448-30913449	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
16	rs2234933	chr16:30913528-30913529	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
17	rs397516648	chr16:30913534-30913535	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
18	rs397516649	chr16:30913595-30913596	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
19	rs397516650	chr16:30913722-30913723	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
20	rs397516651	chr16:30913800-30913801	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
21	rs549844379	chr16:30913827-30913828	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
22	rs568339099	chr16:30913837-30913838	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
23	rs397516652	chr16:30913845-30913846	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
24	rs545480480	chr16:30913861-30913862	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
25	rs397516644	chr16:30913865-30913866	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
26	rs370908045	chr16:30913874-30913875	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
27	rs571883867	chr16:30913890-30913891	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
28	rs539575556	chr16:30913921-30913922	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
29	rs570353656	chr16:30913927-30913928	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
30	rs544834991	chr16:30913934-30913935	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
31	rs375238473	chr16:30913947-30913948	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
32	rs576400812	chr16:30913955-30913956	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
33	rs543796471	chr16:30914046-30914047	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
34	rs561888209	chr16:30914069-30914070	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
35	rs574284237	chr16:30914085-30914086	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
36	rs541711122	chr16:30914107-30914108	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
37	rs367908794	chr16:30914110-30914111	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
38	rs559853599	chr16:30914124-30914125	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
39	rs560008151	chr16:30914135-30914136	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
40	rs117210898	chr16:30914142-30914143	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
41	rs552333693	chr16:30914185-30914186	Active TSS Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
42	rs555974240	chr16:30914204-30914205	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
43	rs564197189	chr16:30914223-30914224	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
44	rs531252771	chr16:30914247-30914248	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
45	rs570605206	chr16:30914255-30914256	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
46	rs114618084	chr16:30914339-30914340	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
47	rs190346372	chr16:30914340-30914341	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
48	rs61735542	chr16:30914362-30914363	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs1870292	chr16:30914395-30914396	Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs547167699	chr16:30914410-30914411	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	18632612	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:495 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:30908400-30913000	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr16:30908400-30913000	Weak transcription	Gastric	stomach
3	chr16:30908400-30913200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
4	chr16:30908400-30913200	Weak transcription	Lung	lung
5	chr16:30908600-30913200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
6	chr16:30908800-30913000	Weak transcription	HSMM	muscle
7	chr16:30908800-30913200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr16:30908800-30913200	Weak transcription	Left Ventricle	heart
9	chr16:30908800-30913200	Weak transcription	Right Atrium	heart
10	chr16:30908800-30913600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr16:30909000-30913000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr16:30909000-30913000	Weak transcription	Primary hematopoietic stem cells	blood
13	chr16:30909000-30913000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr16:30909000-30913000	Weak transcription	Brain Cingulate Gyrus	brain
15	chr16:30909000-30913000	Weak transcription	Fetal Heart	heart
16	chr16:30909000-30913000	Weak transcription	Fetal Lung	lung
17	chr16:30909000-30913000	Weak transcription	Placenta	Placenta
18	chr16:30909000-30913000	Weak transcription	Psoas Muscle	Psoas
19	chr16:30909000-30913000	Weak transcription	NHEK	skin
20	chr16:30909000-30913200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr16:30909000-30913200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
22	chr16:30909000-30913200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr16:30909000-30913200	Weak transcription	HMEC	breast
24	chr16:30909200-30913000	Weak transcription	Right Ventricle	heart
25	chr16:30911400-30913200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr16:30911800-30913000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr16:30912000-30913000	Enhancers	Primary T cells fromperipheralblood	blood
28	chr16:30912400-30913000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr16:30912400-30913000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
30	chr16:30912400-30913000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
31	chr16:30912400-30913000	Enhancers	Liver	Liver
32	chr16:30912400-30913000	Enhancers	Brain Substantia Nigra	brain
33	chr16:30912400-30913000	Enhancers	Colon Smooth Muscle	Colon
34	chr16:30912400-30913000	Enhancers	Duodenum Smooth Muscle	Duodenum
35	chr16:30912400-30913000	Enhancers	Fetal Thymus	thymus
36	chr16:30912400-30913000	Enhancers	Pancreas	Pancrea
37	chr16:30912400-30913200	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr16:30912400-30913200	Enhancers	Primary B cells from peripheral blood	blood
39	chr16:30912400-30913200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
40	chr16:30912400-30913200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr16:30912400-30913200	Enhancers	Spleen	Spleen
42	chr16:30912400-30913400	Flanking Active TSS	HepG2	liver
43	chr16:30912400-30913600	Enhancers	Stomach Mucosa	stomach
44	chr16:30912600-30913000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr16:30912600-30913000	Enhancers	Breast Myoepithelial Primary Cells	Breast
46	chr16:30912600-30913000	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr16:30912600-30913000	Enhancers	Primary B cells from cord blood	blood
48	chr16:30912600-30913000	Enhancers	Primary hematopoietic stem cells short term culture	blood
49	chr16:30912600-30913000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
50	chr16:30912600-30913000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links